Trial Profile
Phase II Study of Afatinib Plus Chemotherapy in Patients With Esophageal and Lung Squamous Cell Carcinoma
Status:
Not yet recruiting
Phase of Trial:
Phase II
Latest Information Update: 03 Jul 2020
Price :
$35
*
At a glance
- Drugs Afatinib (Primary)
- Indications Lung cancer; Oesophageal cancer; Squamous cell cancer
- Focus Therapeutic Use
- 05 Apr 2018 New trial record